Clinical trial
Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating…
NCT00040898 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00040898 |
|---|---|
| Title | Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed |
| Official title | Sho-Saiko-To After Ablation for Non-Resectable Hepatocellular Carcinoma (HCC): A Phase II Trial With Historical Control |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Cancer |
| Intervention type | Dietary Supplement |
| Interventions | Sho-saiko-to |
| Start date | Jan 1, 2001 |
| Primary completion | Jan 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: